Showing posts with label india. Show all posts
Showing posts with label india. Show all posts

14 February 2023

Moody: the works

A list of links to all my non-tech writings:

Essays

Glanglish
 - with audio versions new post

Travel writings

Novels

09 November 2020

Egyptian Romance: a novel about travel

Once again, many people are under lockdown.  Once again, travel is hard, or impossible.  During the first lockdown, I published my black notebooks recording most of my travels over the last thirty-odd years.  So I thought this second lockdown might be a good moment to publish some more travel-related writing.

"Egyptian Romance" is a novel, but one based on information I gathered during my own trip to Egypt in 1990, which I published as a series of four posts earlier this year.  It represents a re-working of my black books from that trip in a form that some may find easier to read.  It can therefore be seen as part of a series, which includes A Partial India - a re-working of my travel notebook for India, and Walks with Lorenzetti, which re-visits a 1988 trip I made to Venice

Empire's End

or

The Tale of a Tourist


01 August 2020

Walks with Lorenzetti: Venice, Memory, Tourism

Just as A Partial India was a re-working of my travel notebook for India, so Walks with Lorenzetti re-visits a 1988 trip I made to Venice.  A Partial India and the notes it is based on try to capture the unrepeatable impact of seeing India for the first time.  Walks with Lorenzetti is quite different.  Although it was a particularly intense few days in Venice, it was far from my first trip there.  I brought with me other memories of the city and elsewhere, as well as various kinds of relevant knowledge built up over the years before.

Walks with Lorenzetti therefore goes beyond simply re-working one of my travel notebooks.  It weaves in other major strands, including three of the city's greatest creators and their art: the music of Vivaldi, the paintings of Canaletto, and the writing of Goldoni.  Above all, it follows in the footsteps of another book: Guido Lorenzetti's Venice and its Lagoona forgotten masterpiece that deserves to be better-known.  I hope the following pages will help to achieve that.

Foreword

Preamble

Introductory Chapters

The book
The itineraries
The man

The Twelve Itineraries

I - First act: eighth itinerary
II - First night movement: Allegro più ch’è possible
III - First portrait: Antonio Vivaldi
IV - Second act: ninth itinerary
V - Second night movement: intermezzo
VI - Second portrait: Carlo Goldoni
VII - Third act: third itinerary
VIII - Third night movement: capriccio
IX - Third portrait: Antonio Canaletto
X - Fourth act: fourth itinerary
XI - Fourth night movement: finale
XII - Fourth portrait: itinerant biographies

Recollections

The personal tempest

Venice and its Lagoon

Souvenir

20 July 2020

A Partial India

In October and November 1986, I went to India for the first time.  It was an important experience,  which I tried to capture as it happened in one of my black travel notebooks, now online as three blog posts.  They are essentially unedited transcriptions of what I wrote as I journeyed.  As such, I hope they possess a certain immediacy and freshness.  But they are also necessarily unstructured, other than by each day's itinerary, rather long, and therefore perhaps rather hard to read.

The experiences of those three weeks were so rich for me I decided to re-work my notes into shorter, more digestible pieces, which together form what I called A Partial India.  Partial, because they obviously captured only a tiny part of the vast land, its people and civilisation; partial, too, because it was born of my gratitude for the experiences India gave me.  

A third of a century later, it describes an India which no longer exists, if it ever did.  Given my inevitable lack of comprehension of India's subtleties during that first journey, perhaps this is the best I can now hope for: that the evident non-existence today of the land I described will make Partial India of mild historical interest to others.

For want of anything better, I organised my memories under arbitrary alphabetical headings, which are as follows:

A is for Agra
B is for Books
C is for Camels
D is for Delhi
E is for English
F is for Fatehpur Sikri
G is for Gandhi
H is for Horns
I is for Incense
J is for Jaipur
K is for Kashmir
L is for Large
M is for Mosques
N is for Nights
O is for Ochre
P is for Poverty
Q is for Queuing
R is for Raj
S is for Shangri-La
T is for Trains
U is for Udaipur
V is for Voyaging
W is for Work
X is for Xenophilia
Y is for Yamuna
Z is for Zenana

26 July 2014

Big Pharma Accused Of Patent Plot Of 'Satanic Magnitude' By South African Health Minister

Here on Techdirt we've written a number of times about India's efforts to provide key drugs to its population at prices that they can afford, and how its approach is beginning to spread to other countries. That's a big worry for Western pharma companies, which see their business model of selling medicines at high prices threatened by newly-assertive nations. The latest to join that club is South Africa. 

On Techdirt.

India Developing Additional National Surveillance System; US Has No Moral High Ground To Protest

Like many other countries, India has been steadily extending its national surveillance capabilities. We wrote about its main Central Monitoring System (CMS) back in May last year, with more details in July. In news that shocked no one, we discovered in September that illegal surveillance is already taking place. And now, via The Economic Times, we learn that India has built another, completely independent system for spying on its citizens

On Techdirt.

24 July 2014

India's Approach To Pharma Patents Under US Attack, But Other BRICS Nations Likely To Adopt It

Techdirt has been reporting for a while on India's growing success in providing its population with access to low-cost generic drugs, making use of the permissions to do so granted by TRIPS. That has naturally earned it the ire of Western pharma companies, which now seem to be striking back, as this post on Infojustice.org explains: 

On Techdirt.

India Wants Students And Researchers To Have The Right To Photocopy Books

Techdirt has run several stories about the difficulties students in emerging economies have when it comes to buying expensive study materials. Back in 2012, Costa Rican students took to the streets to defend their right to photocopy otherwise unaffordable university textbooks. Earlier this year, Indian textbook authors asked for a lawsuit brought by Western publishers against Delhi University and a nearby photocopying shop over alleged infringements to be dropped. A common element to those two stories is that students often resort to making photocopies of books, since they can't afford the originals. According to this story from Calcutta's The Telegraph, it seems that the Indian government wants to turn the practice into a recognized right

On Techdirt.

23 November 2013

India Joins The Super-Snooper's Club (No Legality Required)

One of the many benefits of Edward Snowden's leaks about NSA spying is that it is flushing out similar activity around the world. Tim Cushing wrote recently about Sweden's illegal snooping, and now The Hindu reveals that India is doing something very similar

On Techdirt.

18 September 2013

Indian Government Quietly Brings In Its 'Central Monitoring System': Total Surveillance Of All Telecommunications

There's a worrying trend around the world for governments to extend online surveillance capabilities to encompass all citizens -- often justified with the usual excuse of combatting terrorism and/or child pornography. The latest to join this unhappy club is India, which has put in place what sounds like a massively intrusive system, as this article from The Times of India makes clear: 

On Techdirt.

20 July 2013

OxyContin And The Art Of 'Evergreening'

A few weeks back, we wrote about the Indian Supreme Court's rejection of Novartis's attempt to use "evergreening" to prolong its patent on Gleevec, sold as Glivec in India. That term refers to the trick of making small changes to a drug, usually one about to come off patent, in order to gain a new monopoly that extends its manufacturer's control over a medicine. But how does that work in practice? 

On Techdirt.

EU Free Trade Agreements With India And Canada Grind To A Halt

Techdirt has been covering the free trade agreement being negotiated between India and the EU for a while now -- that is, as well as anyone can report on something that is being conducted behind closed doors. Despite or maybe even because of that secrecy, one issue in particular has raised concerns: that India's crucial role as supplier of low-cost generics to the world's poor might be under threat. Against that background, this report on the Live Mint site comes as something of a surprise

On Techdirt.

Cambodian Activists Explain Why The EU-India FTA Is A Matter Of Life And Death

One of the many problems with the secretive nature of trade agreements is that it insulates negotiators from the real-world consequences of their actions. That's particularly true for the FTA talks between the EU and India, currently taking place behind closed doors. One of the key issues for the EU side is India's role as a supplier of generic medicines to the world, and India's tough stance on issues like the evergreening of pharma patents. From the various leaks that we have, it seems that the EU is demanding that India toe the line on drug patents, and cut back its supply of low-cost generics to emerging countries. 

On Techdirt.

Western Publishers Sue Delhi University Over Photocopied Textbooks; Students And Authors Fight Back

Back in October last year, we wrote about Costa Rican students taking to the streets to defend their right to photocopy otherwise unaffordable university textbooks. Of course, that's not just a problem in Costa Rica: in many parts of the world, high prices act as a significant barrier to education, and it will come as no surprise that photocopying is an accepted practice in many countries. 

On Techdirt.

14 April 2013

Indian Supreme Court Rejects Trivial 'Evergreening' Of Pharma Patents


Back in October last year, in the context of India showing itself increasingly sceptical about pharma patents that drive up drug prices beyond the reach of its citizens, we wrote about an important court battle over Novartis's drug Gleevec, sold as Glivec in India. The definitive judgement from India's Supreme Court was announced today, reported here by The Guardian:

31 March 2013

India Says: 'There Is No Direct Correlation Between IP And Innovation'

Techdirt has been pointing out for years that more patents is not the same thing as more innovation, even though many around the world would have us believe otherwise. It seems the message is finally getting through: here's a remarkable statement from India on the subject of innovation and small- and medium-sized companies, made at a TRIPS Council meeting: 

On Techdirt.

10 March 2013

Bizarre: Indian Government Orders Censorship Of One Its Own Sites

Techdirt has been tracking for some time the worrying moves in India that have involved censoring the Twitter accounts of journalists and political groups, or blocking sites. But this bizarre story from the Times of India goes beyond these in a number of ways

On Techdirt.

10 February 2013

Bayer Fights India's Compulsory Licensing Of Cancer Drug By Claiming It Spent $2.5 Billion Developing It

Back in March last year, the Indian government announced that it was granting its first compulsory license, for the anti-cancer drug marketed as Nexavar, whose $70,000 per year price-tag put it out of reach of practically everyone in India. Nexavar's manufacturer, the German pharmaceutical giant Bayer, naturally appealed against that decision, and the hearing before the India Intellectual Property Appeals Board (IPAB) has now begun. Jamie Love has provided a useful report on the proceedings; here's his summary of what's at stake: 

On Techdirt.

06 January 2013

Historic Ruling Against First Modern Drug Patent In India

As Techdirt has reported over the last year, the Indian government is becoming increasingly keen on using cheaper, generic versions of important drugs to treat diseases, rather than paying Western-level prices its people can ill afford. Intellectual Property Watch reports on another instance of the Indian authorities easing the way for low-cost versions by striking down a patent granted to Roche for the treatment of Hepatitis C. As the article explains, it's notable for at least two reasons: 

On Techdirt.

08 December 2012

Indian Village Bans Unmarried Women And Girls From Using Mobile Phones

It's fairly widely accepted that the key digital device in the future will be the mobile phone, not the desktop computer that has had such an impact on Western society for the last few decades. That's partly a question of cost -- if devices are to reach even the poorest in emerging economies, they must be very cheap. But there are also other factors, such as the mobile phone's small size and portability; its rugged design and ability to cope with intermittent power supplies; and the built-in Net connectivity that more or less comes as standard. 

On Techdirt.